Literature DB >> 12207149

Epidemiology of myasthenia gravis: a population-based study in Stockholm, Sweden.

B Kalb1, G Matell, R Pirskanen, M Lambe.   

Abstract

A regional database of myasthenia gravis (MG) patients was used to estimate the prevalence and selected characteristics of the disease in the county of Stockholm, Sweden. The prevalence of MG was 14.1/100,000 (17.1 for women and 10.8 for men). The mean age at onset for women and men was 34.9 and 48.5 years, respectively. About 60% of patients were diagnosed within the first year after initial symptoms. Generalized MG was found in 79% of patients, and 10% had severe symptoms. Almost two thirds of the patients had undergone thymectomy, and 30% needed immunosuppressive treatment. The increase in the prevalence of MG since the 1960s probably reflects an improvement in prognosis and higher detection rates of patients with milder symptoms. A delay in diagnosis indicates that early signs and symptoms of MG are still not well known by all doctors. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12207149     DOI: 10.1159/000065639

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  20 in total

1.  Long-term outcome of 424 childhood-onset myasthenia gravis patients.

Authors:  Mengcui Gui; Xuan Luo; Jing Lin; Yue Li; Min Zhang; Xiaofan Zhang; Mingshan Yang; Wei Wang; Bitao Bu
Journal:  J Neurol       Date:  2015-01-15       Impact factor: 4.849

Review 2.  Selective IgA deficiency in autoimmune diseases.

Authors:  Ning Wang; Nan Shen; Timothy J Vyse; Vidya Anand; Iva Gunnarson; Gunnar Sturfelt; Solbritt Rantapää-Dahlqvist; Kerstin Elvin; Lennart Truedsson; Bengt A Andersson; Charlotte Dahle; Eva Ortqvist; Peter K Gregersen; Timothy W Behrens; Lennart Hammarström
Journal:  Mol Med       Date:  2011-08-04       Impact factor: 6.354

Review 3.  A systematic review of population based epidemiological studies in Myasthenia Gravis.

Authors:  Aisling S Carr; Chris R Cardwell; Peter O McCarron; John McConville
Journal:  BMC Neurol       Date:  2010-06-18       Impact factor: 2.474

4.  Myasthenia gravis: a long term follow-up study of Swedish patients with specific reference to thymic histology.

Authors:  Natalie Tsinzerling; Ann-Kari Lefvert; Georg Matell; Ritva Pirskanen-Matell
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03-12       Impact factor: 10.154

5.  Cholinergic Crisis Caused by Cholinesterase Inhibitors: a Retrospective Nationwide Database Study.

Authors:  Hiroyuki Ohbe; Taisuke Jo; Hiroki Matsui; Kiyohide Fushimi; Hideo Yasunaga
Journal:  J Med Toxicol       Date:  2018-06-15

Review 6.  Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases.

Authors:  Glinda S Cooper; Milele L K Bynum; Emily C Somers
Journal:  J Autoimmun       Date:  2009-10-09       Impact factor: 7.094

7.  Depression in myasthenia gravis: a heterogeneous and intriguing entity.

Authors:  Yury V Gavrilov; Tatjana M Alekseeva; Olga A Kreis; Philipp O Valko; Konrad P Weber; Yulia Valko
Journal:  J Neurol       Date:  2020-03-05       Impact factor: 4.849

Review 8.  The role of MuSK in synapse formation and neuromuscular disease.

Authors:  Steven J Burden; Norihiro Yumoto; Wei Zhang
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-05-01       Impact factor: 10.005

9.  Juvenile myasthenia gravis: a paediatric perspective.

Authors:  Maria F Finnis; Sandeep Jayawant
Journal:  Autoimmune Dis       Date:  2011-11-01

10.  Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity.

Authors:  Claudia Sardu; Eleonora Cocco; Alessandra Mereu; Roberta Massa; Alessandro Cuccu; Maria Giovanna Marrosu; Paolo Contu
Journal:  PLoS One       Date:  2012-03-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.